vs
Side-by-side financial comparison of Cheche Group Inc. (CCG) and Invivyd, Inc. (IVVD). Click either name above to swap in a different company.
Cheche Group Inc. is the larger business by last-quarter revenue ($32.8M vs $17.2M, roughly 1.9× Invivyd, Inc.). Cheche Group Inc. runs the higher net margin — 0.5% vs -64.3%, a 64.8% gap on every dollar of revenue.
Cheche Group Inc. is a leading automotive digital service provider headquartered in China. It offers integrated solutions including auto insurance intermediary services, smart auto after-sales support, and connected vehicle technology products, serving individual car owners, auto dealerships, and insurance partners across domestic and select Southeast Asian markets.
Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.
CCG vs IVVD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $32.8M | $17.2M |
| Net Profit | $153.6K | $-11.1M |
| Gross Margin | 5.7% | — |
| Operating Margin | — | -73.0% |
| Net Margin | 0.5% | -64.3% |
| Revenue YoY | — | 24.5% |
| Net Profit YoY | — | 40.0% |
| EPS (diluted) | $0.00 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $32.8M | — | ||
| Q4 25 | — | $17.2M | ||
| Q3 25 | — | $13.1M | ||
| Q2 25 | $26.0M | $11.8M | ||
| Q1 25 | — | $11.3M | ||
| Q4 24 | $18.6M | $13.8M | ||
| Q3 24 | — | $9.3M | ||
| Q2 24 | $36.1M | $2.3M |
| Q1 26 | $153.6K | — | ||
| Q4 25 | — | $-11.1M | ||
| Q3 25 | — | $-10.5M | ||
| Q2 25 | $-492.4K | $-14.7M | ||
| Q1 25 | — | $-16.3M | ||
| Q4 24 | $-196.7K | $-18.4M | ||
| Q3 24 | — | $-60.7M | ||
| Q2 24 | $-7.6M | $-47.2M |
| Q1 26 | 5.7% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.9% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 4.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | -73.0% | ||
| Q3 25 | — | -84.0% | ||
| Q2 25 | -2.0% | -127.8% | ||
| Q1 25 | — | -149.7% | ||
| Q4 24 | -0.3% | -139.1% | ||
| Q3 24 | — | -670.0% | ||
| Q2 24 | -4.7% | -2175.2% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | — | -64.3% | ||
| Q3 25 | — | -79.7% | ||
| Q2 25 | -1.9% | -124.4% | ||
| Q1 25 | — | -144.1% | ||
| Q4 24 | -1.1% | -133.5% | ||
| Q3 24 | — | -653.1% | ||
| Q2 24 | -21.0% | -2086.9% |
| Q1 26 | $0.00 | — | ||
| Q4 25 | — | $0.02 | ||
| Q3 25 | — | $-0.06 | ||
| Q2 25 | $-0.01 | $-0.12 | ||
| Q1 25 | — | $-0.14 | ||
| Q4 24 | $-0.00 | $-0.14 | ||
| Q3 24 | — | $-0.51 | ||
| Q2 24 | — | $-0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $20.0M | $226.7M |
| Total DebtLower is stronger | $193.3K | — |
| Stockholders' EquityBook value | — | $241.5M |
| Total Assets | $203.5M | $276.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $20.0M | — | ||
| Q4 25 | — | $226.7M | ||
| Q3 25 | — | $85.0M | ||
| Q2 25 | $23.1M | $34.9M | ||
| Q1 25 | — | $48.1M | ||
| Q4 24 | $21.1M | $69.3M | ||
| Q3 24 | — | $106.9M | ||
| Q2 24 | $28.2M | $147.9M |
| Q1 26 | $193.3K | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $690.0K | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $241.5M | ||
| Q3 25 | — | $93.1M | ||
| Q2 25 | $47.1M | $42.8M | ||
| Q1 25 | — | $54.1M | ||
| Q4 24 | $49.1M | $67.5M | ||
| Q3 24 | — | $83.2M | ||
| Q2 24 | $48.6M | $140.6M |
| Q1 26 | $203.5M | — | ||
| Q4 25 | — | $276.9M | ||
| Q3 25 | — | $139.2M | ||
| Q2 25 | $177.3M | $89.1M | ||
| Q1 25 | — | $103.7M | ||
| Q4 24 | $177.7M | $129.5M | ||
| Q3 24 | — | $161.9M | ||
| Q2 24 | $139.3M | $177.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-15.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $-15.5M | ||
| Q3 25 | — | $-8.3M | ||
| Q2 25 | $-44.7M | $-13.3M | ||
| Q1 25 | — | $-21.1M | ||
| Q4 24 | $-15.8M | $-37.6M | ||
| Q3 24 | — | $-41.1M | ||
| Q2 24 | $-1.0K | $-41.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-13.3M | ||
| Q1 25 | — | $-21.3M | ||
| Q4 24 | $-16.0M | $-37.6M | ||
| Q3 24 | — | $-41.1M | ||
| Q2 24 | $-1.1K | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -112.9% | ||
| Q1 25 | — | -188.2% | ||
| Q4 24 | -85.9% | -272.2% | ||
| Q3 24 | — | -441.6% | ||
| Q2 24 | -0.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | 1.2% | 0.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | 0.0% | 0.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
